Page last updated: 2024-08-16

ribavirin and Dyslipidemias

ribavirin has been researched along with Dyslipidemias in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Lai, WT; Lee, HC; Liang, PC; Lin, YH; Lin, ZY; Yeh, ML; Yu, ML1
Izumi, T; Kawagishi, N; Kimura, M; Kudo, Y; Maehara, O; Miyoshi, H; Morikawa, K; Nakai, M; Nakamura, A; Natsuizaka, M; Nishida, M; Ogawa, K; Ohara, M; Sakamoto, N; Sho, T; Suda, G; Suzuki, K; Umemura, M1
Kohli, A; Kottilil, S; Masur, H; Meissner, EG; Osinusi, A; Remaley, AT; Sampson, M; Sidharthan, S; Tang, L; Townsend, K1
Haroon, W; Husain, A; Khan, Z; Mirza, SA; Nazir, L; Shaikh, MI1

Trials

1 trial(s) available for ribavirin and Dyslipidemias

ArticleYear
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
    AIDS research and human retroviruses, 2016, Volume: 32, Issue:5

    Topics: Antiviral Agents; Benzimidazoles; Cardiovascular Diseases; Cholesterol, LDL; Coinfection; Drug Therapy, Combination; Dyslipidemias; Female; Fluorenes; Furans; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Quinolines; Ribavirin; Sofosbuvir; Thiophenes; Uridine Monophosphate

2016

Other Studies

3 other study(ies) available for ribavirin and Dyslipidemias

ArticleYear
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication.
    The Kaohsiung journal of medical sciences, 2020, Volume: 36, Issue:11

    Topics: Aged; Antiviral Agents; Carbamates; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Ribavirin; Risk; RNA, Viral; Sofosbuvir; Sustained Virologic Response; Triglycerides; Valine

2020
Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis.
    PloS one, 2018, Volume: 13, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Atherosclerosis; Cholesterol, LDL; Dyslipidemias; Fatty Liver; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lipid Metabolism; Liver; Male; Middle Aged; Ribavirin; Risk Factors; Sustained Virologic Response

2018
Interferon-induced central retinal vein thrombosis.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2012, Volume: 22, Issue:11

    Topics: Anticholesteremic Agents; Anticoagulants; Antiviral Agents; Dyslipidemias; Female; Hepatitis C, Chronic; Humans; Interferons; Middle Aged; Retinal Vein Occlusion; Ribavirin; Treatment Outcome; Visual Acuity

2012